Intrahepatic cholangiocarcinoma: current management and emerging therapies.
about
Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells.Characterization and prognostic significance of mortalin, Bcl-2 and Bax in intrahepatic cholangiocarcinoma.Curcumol Exerts Anticancer Effect in Cholangiocarcinoma Cells via Down-Regulating CDKL3.
P2860
Intrahepatic cholangiocarcinoma: current management and emerging therapies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Intrahepatic cholangiocarcinoma: current management and emerging therapies.
@en
Intrahepatic cholangiocarcinoma: current management and emerging therapies.
@nl
type
label
Intrahepatic cholangiocarcinoma: current management and emerging therapies.
@en
Intrahepatic cholangiocarcinoma: current management and emerging therapies.
@nl
prefLabel
Intrahepatic cholangiocarcinoma: current management and emerging therapies.
@en
Intrahepatic cholangiocarcinoma: current management and emerging therapies.
@nl
P2093
P2860
P1476
Intrahepatic cholangiocarcinoma: current management and emerging therapies.
@en
P2093
Allison B Weisbrod
Amir A Rahnemai-Azar
Carl Schmidt
Mary Dillhoff
P2860
P304
P356
10.1080/17474124.2017.1309290
P577
2017-03-20T00:00:00Z